NCT03563781View on ClinicalTrials.gov

SEntine Lymph Node in earLY Ovarian Cancer (SELLY)

NACompletedINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

November 11, 2017

Primary Completion Date

July 29, 2022

Study Completion Date

May 5, 2023

Conditions

Sentinel Lymph NodeOvarian Cancer Stage I

Interventions

PROCEDURE

Sentinel node detection

Patients will receive injection of tracer in the ovarian ligaments to identify the lymphatic drainage of the affected ovary and ultimately the sentinel node. Afterwards, systematic lymphadenectomy will be accomplished according to current guidelines.

Trial Locations (1)

Unknown

Giovannni Scambia, Rome

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT03563781 - SEntine Lymph Node in earLY Ovarian Cancer (SELLY) | Biotech Hunter | Biotech Hunter